CUAMC
AARD

China Universal Asset Management Company’s Aardvark Therapeutics AARD Stock Holding History

China Universal Asset Management Company’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20K Sell
3,472
-392
-10% -$1.83K ﹤0.01% 496
2026
Q1 		$14.6K Buy
3,864
+316
+9% +$3.28K ﹤0.01% 497
2025
Q4 		$46.6K Buy
+3,548
New +$44.3K ﹤0.01% 459

Other funds holding AARD

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HHCP
Hilton Head Capital Partners Hilton Head Island, South Carolina $198M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

China Universal Asset Management Company's AARD Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Aardvark Therapeutics (AARD) stake by 10% in Q2 2026, selling an estimated $1.83K and leaving 3,472 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #496.

China Universal Asset Management Company first reported a position in AARD in Q4 2025 and has held it in 3 quarters since. The position peaked at $46.6K in Q4 2025. 13 funds tracked by Wall St. Rank hold AARD as of Q2 2026.

  • China Universal Asset Management Company held 3,472 shares of Aardvark Therapeutics worth $20K as of Q2 2026.
  • China Universal Asset Management Company sold 392 Aardvark Therapeutics shares in Q2 2026, an estimated $1.83K.
  • Aardvark Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #496 holding.
  • China Universal Asset Management Company first reported a position in Aardvark Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • China Universal Asset Management Company's Aardvark Therapeutics position peaked at $46.6K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.